Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
The Journal of Investigative Dermatology|October 1, 1991
HLA DQB1*0301 allele is involved in the susceptibility to erythema multiformeI Khalil, V Lepage, C Douay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderlyH Tilly, S Castaigne, D Bordessoule, et al.
Leukemia|September 3, 2004
Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylateN Boissel, P Rousselot, E Raffoux, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemiaJ Zhu, M H Koken, F Quignon, et al.
British Journal of Haematology|February 1, 1979
Identification of a pure splenic form of chronic lymphocytic leukaemiaG Dighiero, D Charron, P Debre, et al.
The Journal of Clinical Investigation|April 1, 1990
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitusI Khalil, L d'Auriol, M Gobet, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patientsC Jacquillat, M Weil, M F Auclerc, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
The Journal of Investigative Dermatology|October 1, 1991
HLA DQB1*0301 allele is involved in the susceptibility to erythema multiformeI Khalil, V Lepage, C Douay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderlyH Tilly, S Castaigne, D Bordessoule, et al.
Leukemia|September 3, 2004
Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylateN Boissel, P Rousselot, E Raffoux, et al.
Acta Haematologica|January 1, 1987
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literatureC Chomienne, Y Najean, L Degos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemiaJ Zhu, M H Koken, F Quignon, et al.
British Journal of Haematology|February 1, 1979
Identification of a pure splenic form of chronic lymphocytic leukaemiaG Dighiero, D Charron, P Debre, et al.
The Journal of Clinical Investigation|April 1, 1990
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitusI Khalil, L d'Auriol, M Gobet, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patientsC Jacquillat, M Weil, M F Auclerc, et al.
Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.
Pageof 34